Objectives: Women with acute myocardial infarction (AMI) previously received less invasive evaluation and experienced higher mortality than men. After improvements in AMI care it is unclear whether gender differences still exist in management and outcome of AMI. Methods: All patients admitted to Ullevål University Hospital for AMI during 2006 and 2007 were included in this cohort study. Predefined data were recorded during the hospital stay, and the survival status of the patients was ascertained on June 30, 2008. Results: A total of 931 women and 2,174 men were included. No gender differences were observed in treatment delay or age-adjusted odds ratio (OR) of invasive evaluation in ST-elevation myocardial infarction (STEMI). In non-ST-elevation myocardial infarction (NSTEMI), women were less likely than men to undergo coronary angiography (adjusted OR 0.72, 95% CI 0.53–0.99, p = 0.044) and percutaneous coronary intervention (adjusted OR 0.60, 95% CI 0.47–0.76, p = 0.0001). Age-adjusted in-hospital mortality and long-term survival were similar between men and women. Conclusions: Women with STEMI experienced similar treatment delays and odds of invasive evaluation as men. However, gender differences in invasive evaluation were still observed in NSTEMI patients. No sex differences were observed in age-adjusted early and long-term mortality.

1.
Hasdai D, Porter A, Rosengren A, Behar S, Boyko V, Battler A: Effect of gender on outcomes of acute coronary syndromes. Am J Cardiol 2003;91:1466–1469, A6.
2.
Anand SS, Xie CC, Mehta S, et al: Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol 2005;46:1845–1851.
3.
Radovanovic D, Erne P, Urban P, Bertel O, Rickli H, Gaspoz JM: Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry. Heart 2007;93:1369–1375.
4.
Milcent C, Dormont B, Durand-Zaleski I, Steg PG: Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database. Circulation 2007;115:833–839.
5.
Vikman S, Airaksinen KE, Tierala I, et al: Gender-related differences in the management of non-ST-elevation acute coronary syndrome patients. Scand Cardiovasc J 2007;41:287–293.
6.
Goldberg RJ, Gurwitz JH, Gore JM: Duration of, and temporal trends (1994–1999) in, prehospital delay in patients with acute myocardial infarction: the second National Registry of Myocardial Infarction. Arch Intern Med 1999;159:2141–2147.
7.
Jacobs AK, Johnston JM, Haviland A, et al: Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry. J Am Coll Cardiol 2002;39:1608–1614.
8.
Singh M, Rihal CS, Gersh BJ, et al: Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol 2008;51:2313–2320.
9.
Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Klebaek H, Thayssen P, et al: A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733–742.
13.
Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined: a consensus document of the joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959–969.
14.
Altman DG: Practical statistics for medical research. London, Chapman & Hall, 1996.
15.
Mandelzweig L, Battler A, Boyko V, et al: The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006;27:2285–2293.
16.
Lagerqvist B, Safstrom K, Stahle E, Wallentin L, Swahn E: Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators. J Am Coll Cardiol 2001;38:41–48.
17.
Clayton TC, Pocock SJ, Henderson RA, Poole-Wilson PA, Shaw TR, Knight R, Fox, KA: Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA-3 trial. Eur Heart J 2004;25:1641–1650.
18.
O’Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ, et al: Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA 2008;300:71–80.
19.
Dey S, Flather MD, Devlin G, Brieger D, Gurfinkel EP, Steg PG, et al: Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Heart 2009;95:20–26. DOI: 10.1136/hrt.2007.138537.
20.
Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, van der Werf F, et al: Sex, clinical presentation and outcome in patients with acute coronary syndromes. N Engl J Med 1999;341:226–232.
21.
Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM: Sex-based differences in early mortality after myocardial infarction. N Engl J Med 1999;341:217–225.
22.
Simon T, Mary-Krause M, Cambou JP, et al: Impact of age and gender on in-hospital and late mortality after acute myocardial infarction: increased early risk in younger women: results from the French nationwide USIC registries. Eur Heart J 2006;27:1282–1288.
23.
Bonarjee VV, Rosengren A, Snapinn SM, James MK, Dickstein K: Sex-based short- and long-term survival in patients following complicated myocardial infarction. Eur Heart J 2006;27:2177–2183.
24.
Jneid H, GC Fonarow, Cannon CP, Hernandez AF, Palacios IF, Karee AO, et al: Sex differences in medical care and early death after acute myocardial infarction. Circulation 2008;118:2803–2810.
25.
Giannitsis E, Steen H, Kurz K, Ivandic B, Simon AC, Futterer S, Schild C, Isfort P, Jaffe AS, Katus HA: Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol 2008;51:307–314.
26.
Bøhmer E, Hoffmann P, Arnesen H, Seljeflot I, Halvorsen S: Troponin T concentration 3 days after ST-elevation myocardial infarction predicts infarct size and function. Cardiology 2009;113:207–212.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.